Cargando…
Five-year follow-up study of stage I-IV rectal cancer including EGFR immunoexpression and p21 immunoactivity
INTRODUCTION: Both environmental and genetic factors increase the likelihood of developing rectal cancer. AIM: To assess the EGFR and p21 immunoreactivity in rectal cancer and to assess its relationship with the clinical outcome. MATERIAL AND METHODS: Applying exclusion criteria, 102 patients with s...
Autores principales: | Kozłowska-Geller, Monika, Głuszek, Stanisław, Lewitowicz, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690949/ https://www.ncbi.nlm.nih.gov/pubmed/34976241 http://dx.doi.org/10.5114/pg.2021.104980 |
Ejemplares similares
-
P21 is not a prognostic marker for rectal cancer – five-year follow up study of rectal cancer in stages I–IV
por: Kozłowska-Geller, Monika A., et al.
Publicado: (2021) -
Could veterinarians be immune to contracting SARS-CoV-2?
por: Kozłowska-Geller, Monika Anna, et al.
Publicado: (2022) -
Theranostics on the immunoactivity of T cells
por: Shi, Changrong, et al.
Publicado: (2023) -
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2022) -
Highly modified and immunoactive N-glycans of the canine heartworm
por: Martini, Francesca, et al.
Publicado: (2019)